The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration

Journal of Gene Medicine

Volumn 14, Issue 1, 2012, Pages 20-34

  Williams, Ryan R ^a   Pearse, Damien D ^a   Tresco, Patrick A ^b   Bunge, Mary Bartlett ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Adeno associated viral vector; Axon regeneration; Enhanced green fluorescent protein; Schwann cell; Spinal cord injury; Wallerian degeneration

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN STEM; CONTROLLED STUDY; FEMALE; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SEROTYPE; THORACIC SPINAL CORD;

ANIMALS; AXONS; BRAIN STEM; DEPENDOVIRUS; FEMALE; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; NERVE REGENERATION; NEURONS; RATS; STAINING AND LABELING; STEREOTAXIC TECHNIQUES; WALLERIAN DEGENERATION;

ADENO-ASSOCIATED VIRUS; ANIMALIA; RATTUS; WALLERIA;

EID: 84862966021     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1628     Document Type: Article

References (90)

1. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 2007; 30: 153-179.
2. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-156.
3. Bunge MB, Pearse DD. Transplantation strategies to promote repair of the injured spinal cord. J Rehabil Res Dev 2003; 40: 55-62.
4. Reier PJ. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 2004; 1: 424-451.
5. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611-1682.
6. Bulsara KR, Iskandar BJ, Villavicencio AT, Skene JH. A new millennium for spinal cord regeneration: growth-associated genes. Spine 2002; 27: 1946-49.
7. Goldberg JL. Intrinsic neuronal regulation of axon and dendrite growth. Curr Opin Neurobiol 2004; 14: 551-557.
8. Muramatsu R, Ueno M, Yamashita T. Intrinsic regenerative mechanisms of central nervous system neurons. Biosci Trends 2009; 3: 179-183.
9. Di Giovanni S. Molecular targets for axon regeneration: focus on the intrinsic pathways. Expert Opin Ther Targets 2009; 13: 1387-1398.
10. Liu K, Tedeschi A, Park KK, He Z. Neuronal intrinsic mechanisms of axon regeneration. Annu Rev Neurosci 2011; 34: 131-152.
11. Sun F, He Z. Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol 2010; 20: 510-518.
12. Bonilla IE, Tanabe K, Strittmatter SM. Small proline-rich repeat protein 1 A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 2002; 22: 1303-1315.
13. Schmitt AB, Breuer S, Liman J, et al. Identification of regeneration-associated genes after central and peripheral nerve injury in the adult rat. BMC Neurosci 2003; 4: 8.
14. Fischer D, Petkova V, Thanos S, Benowitz LI. Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J Neurosci 2004; 24: 8726-8740.
15. Szpara ML, Vranizan K, Tai YC, Goodman CS, Speed TP, Ngai J. Analysis of gene expression during neurite outgrowth and regeneration. BMC Neurosci 2007; 8: 100.
16. Veldman MB, Bemben MA, Thompson RC, Goldman D. Gene expression analysis of zebrafish retinal ganglion cells during optic nerve regeneration identifies KLF6a and KLF7a as important regulators of axon regeneration. Dev Biol 2007; 312: 596-612.
17. Taylor AM, Berchtold NC, Perreau VM, Tu CH, Li Jeon N, Cotman CW. Axonal mRNA in uninjured and regenerating cortical mammalian axons. J Neurosci 2009; 29: 4697-4707.
18. Blackmore MG, Moore DL, Smith RP, Goldberg JL, Bixby JL, Lemmon VP. High content screening of cortical neurons identifies novel regulators of axon growth. Mol Cell Neurosci 2010; 44: 43-54.
19. Michaelevski I, Segal-Ruder Y, Rozenbaum M, et al. Signaling to transcription networks in the neuronal retrograde injury response. Sci Signal 2010; 3: ra53.
20. Gumy LF, Yeo GS, Tung YC, et al. Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA 2011; 17: 85-98.
21. Park KK, Liu K, Hu Y, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-966.
22. Moore DL, Blackmore MG, Hu Y, et al. KLF family members regulate intrinsic axon regeneration ability. Science 2009; 326: 298-301.
23. Kobbert C, Aoos R, Bechmann I, Lanciego J, Mey J, Thanos S. Current concepts in neuroanatomical tracing. Prog Neurobiol 2000; 62: 327-351.
24. Vercelli A, Repici M, Garbossa D, Grimaldi A. Recent techniques for tracing pathways in the central nervous system of developing and adult mammals. Brain Res Bull 2000; 51: 11-28.
25. Zhang G, Gurtu V, Kain SR. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 1996; 227: 707-711.
26. Hechler D, Nitsch R, Hendrix S. Green-fluorescent-protein-expressing mice as models for study of axon growth and regeneration in vitro. Brain Res Rev 2006; 52: 160-169.
27. Harvey AR, Ehlert E, Wit J, et al. Use of GFP to analyze morphology, connectivity, and function of cells in the central nervous system. Methods Mol Biol 2009; 515: 63-95.
28. Mandel RJ, Burger C. Clinical trials in neurological disorders using AAV vectors: promises and challenges. Curr Opin Mol Ther 2004; 6: 482-490.
29. Mandel RJ, Manfredsson FP, Foust KD, et al. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 2006; 13: 463-483.
30. Mueller C, Flotte TR. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008; 15: 858-863.
31. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in mammalian brain. Nat Gen 1994; 8: 148-154.
32. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus vector. Brain Res 1996; 713: 99-107.
33. Mandel RJ, Spratt SK, Snyder RO, Leff SE. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopanime-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci USA 1997; 94: 14083-14088.
34. Xiao X, Li T, McCown TJ, Samulski RJ. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol 1997; 144: 113-124.
35. During MJ, Samulski RJ, Elsworth JD, et al. In vivo expression of therapeutic human genes for dopamine production in the caudate of MPTP-treated monkeys using an AAV vector. Gene Ther 1998; 5: 820-827.
36. Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432.
37. Alisky JM, Davidson BL. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases. Hum Gene Ther 2000; 11: 2315-2329.
38. Harvey AR, Kamphuis W, Eggers R, et al. Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors. Mol Cell Neurosci 2002; 21: 141-157.
39. Yang GS, Schmidt M, Yan Z, et al. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol 2002; 76: 7651-7660.
40. Lotery AJ, Yang GS, Mullins RF, et al. Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther 2003; 14: 1663-1671.
41. Ruitenberg MJ, Eggers R, Boer GJ, Verhaagen J. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 2002; 28: 182-194.
42. Tenenbaum L, Chtarto A, Lehtonen E, Velu T, Brotchi J, Levivier M. Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 2004; 6: S212-S222.
43. Burger C, Nash K, Mandel RJ. Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 2005; 16: 781-791.
44. Terzi D, Zachariou V. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders. Biotechnol J 2008; 3: 1555-1563.
45. Chamberlin NL, Du B, Lacalle S, Saper CB. Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 1998; 793: 169-175.
46. Foust KD, Flotte TR, Reier PJ, Mandel RJ. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat. Hum Gene Ther 2008; 19: 71-82.
47. Blits B, Derks S, Twisk J, Ehlert E, Prins J, Verhaagen J. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors. J Neurosci Methods 2010; 185: 257-263.
48. Hutson TH, Verhaagen J, Yáñez-Muñoz RJ, Moon LD. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector. Gene Ther 2011, May 12 [Epub ahead of print].
49. Fitzsimons HL, Mckenzie JM, During MJ. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 2001; 8: 1675-1681.
50. Manfredsson FP, Burger C, Rising AC, et al. Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. Mol Ther 2009; 17: 1857-1867.
51. Flotte TR, Afione SA, Zeitlin PL. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 1994; 11: 517-521.
52. Duan D, Sharma P, Yang J, et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episonal persistence in muscle tissue. J Virol 1998; 72: 8568-8577.
53. McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004; 38: 819-845.
54. Yang J, Zhou W, Zhang Y, Zidon T, Ritchie T, Engelhardt JF. Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J Virol 1999; 73: 9468-9477.
55. Bunge MB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 2008; 31: 262-269.
56. Loeb JE, Cordier WS, Harris ME, Weitzman MD, Hope TJ. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implication for gene therapy. Hum Gene Ther 1999; 10: 2295-2305.
57. Xu R, Janson CG, Mastakov M, et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther 2001; 8: 1323-1332.
58. Klein RL, Hamby ME, Gong Y, et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 2002; 176: 66-74.
59. Morrissey TK, Kleitman N, Bunge RP. Isolation and functional characterization of schwann cells derived from adult peripheral nerve. J Neurosci 1991; 11: 2433-2442.
60. Hill CE, Moon LD, Wood PM, Bunge MB. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 2003; 53: 338-343.
61. Steward O, Zheng B, Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol 2003; 459: 1-8.
62. Harvey AR, Hellstrom M, Rodger J. Gene therapy and transplantation in the retinofugal pathway. Prog Brain Res 2009; 175: 151-161.
63. Leaver SG, Cui Q, Bernard O, Harvey AR. Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice. Eur J Neurosci 2006; 24: 3323-3332.
64. Leaver SG, Cui Q, Plant GW, et al. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult retinal ganglion cells. Gene Ther 2006; 13: 1328-1341.
65. Andrews MR, Czvitkovich S, Dassie E, et al. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci 2009; 29: 5546-5557.
66. Sternberger LA, Sternberger NH. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 1983; 80: 6126-6130.
67. Meller D, Eysel UT, Schmidt-Kastner R. Transient immunohistochemical labeling of rat retinal axons during Wallerian degeneration by a monoclonal antibody to neurofilaments. Brain Res 1994; 648: 162-166.
68. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
69. Bannerman PG, Hahn A. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice. J Neurol Sci 2007; 260: 23-32.
70. Dziedzic T, Metz I, Dallenga T, et al. Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 2010; 20: 976-985.
71. Alisky JM, Hughes SM, Sauter SL, et al. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 2000; 11: 2669-2673.
72. Alisky JM, Davidson BL. Gene transfer to brain and spinal cord using recombinant adenoviral vectors. Methods Mol Biol 2004; 246: 91-120.
73. Manfredsson FP, Mandel RJ. Development of gene therapy for neurological disorders. Discov Med 2010; 9: 204-211.
74. Planchamp V, Bermel C, Tönges L, et al. BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity. Brain 2008; 131: 2606-2619.
75. Vulchanova L, Schuster DJ, Belur LR, et al. Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol Pain 2010; 6: 31.
76. Davies SJ, Goucher DR, Doller C, Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810-5822.
77. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 2004; 19: 1226-1242.
78. Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5: 7.
79. Massey JM, Amps J, Viapiano MS, et al. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 2008; 209: 426-445.
80. Bareyre FM, Kerschensteiner M, Misgeld T, Sanes JR. Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury. Nat Med 2005; 11: 1355-1360.
81. Wu D, Yang P, Zhang X, et al. Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion. Mol Ther 2009; 17: 2020-2030.
82. Löw K, Blesch A, Herrmann J, Tuszynski MH. A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury. Gene Ther 2010; 17: 577-591.
83. Wang X, Smith GM, Xu XM. Preferential and bidirectional labeling of the rubrospinal tract with adenovirus-GFP for monitoring normal and injured axons. J Neurotrauma 2011; 28: 635-647.
84. Toriyama M, Sakumura Y, Shimada T, Ishii S, Inagaki N. A diffusion-based neurite length-sensing mechanism involved in neuronal symmetry breaking. Mol Syst Biol 2010; 6: 394.
85. Bridge KE, Berg N, Adalbert R, et al. Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiol Aging 2009; 30: 309-321.
86. Greer JE, McGinn MJ, Povlishock JT. Diffuse traumatic axonal injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in the axotomized neuronal population. J Neurosci 2011; 31: 5089-5105.
87. Corish P, Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 1999; 12: 1035-1040.
88. Brendza RP, Simmons K, Bales KR, Paul SM, Goldberg MP, Holtzman DM. Use of YFP to study amyloid-beta associated neurite alterations in live brain slices. Neurobiol Aging 2003; 24: 1071-1077.
89. Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 2005; 11: 572-577.
90. Enright LE, Zhang S, Murphy TH. Fine mapping of the spatial relationship between acute ischemia and dendritic structure indicates selective vulnerability of layer V neuron dendritic tufts within single neurons in vivo. J Cereb Blood Flow Metab 2007; 27: 1185-1200.